BC Extra | Jan 29, 2010
Top Story

Sinovac raises $57.5 million

Sinovac Biotech Ltd. (NASDAQ:SVA) raised $57.5 million through the sale of 10 million shares at $5.75 in a bumped-up follow-on underwritten by UBS and Piper Jaffray. Sinovac proposed to sell 8.7 million shares last week,...
BC Extra | Jan 21, 2010
Financial News

Sinovac proposes follow-on

Sinovac Biotech Ltd. (NASDAQ:SVA) proposed late Wednesday to sell 8.7 million shares in a follow-on underwritten by UBS and Piper Jaffray. If sold at Sinovac's Wednesday close of $7.51, the company would raise $65 million....
BC Week In Review | Apr 4, 2005
Company News

Sinovac sales and marketing update

SVA launched its Bilive vaccine to prevent hepatitis A and B infection in China. Sinovac Biotech Ltd. (SVA), Beijing, China   Business: Infectious  ...
BC Week In Review | Jan 17, 2005
Clinical News

Bilive regulatory update

SVA received Chinese marketing and sales approval for Bilive, a combined hepatitis A & B vaccine. Sinovac Biotech Ltd. (SVA), Beijing, China   Product: Bilive   Business: Infectious  ...
Items per page:
1 - 4 of 4